Stephens starts TearLab at overweight

Tweet Stephens Inc. has initiated coverage of TearLab (NASDAQ:TEAR; TSX:TLB) with an “overweight” rating and an $11 price target, saying the company is attractively positioned with a unique technology that addresses a large unmet need for the diagnosis and management of dry eye disease.   The stock was quoted at $9.46 Thursday afternoon. “We are [...]

Analysts raise TearLab price targets

Tweet Analysts at Canaccord Genuity, Felt & Co., Roth Capital Markets and Craig-Hallum Capital Group raised their price targets on “buy and strong buy-rated” TearLab (NASDAQ:TEAR; TSX:TLB) after the company’s first quarter results and systems orders beat consensus estimates. The stock was changing hands at $9.03, up 13%, after touching a 52-week high of $9.16 [...]

TearLab Q1 revenue jumps 486%

Tweet First quarter revenue for TearLab (NASDAQ:TEAR; TSX:TLB) rose 486% to $2.5-million from $422,000 a year ago, and was up 54% sequentially from $1.6-million in the fourth quarter of 2012.  The company reported an adjusted net loss of $0.11 per share, beating consensus analyst estimates by a cent. A total of 388 orders for TearLab [...]

ASCRS 2013: TearLab gets another vote of confidence from prominent ophthalmologist

Tweet In an EyeWorld interview at this weekend’s American Society of Cataract and Refractive Surgery (ASCRS)/American Society of Ophthalmic Administrators (ASOA) Symposium and Congress, ophthalmologist Dr. Christopher Starr discussed new diagnostic tests for ocular surface disease, including TearLab’s (NASDAQ:TEAR; TSX:TLB) osmolarity test for the diagnoses and management of dry eye disease. Dr. Starr is an assistant [...]

TearLab launches free smartphone IR app

Tweet TearLab (NASDAQ:TEAR; TSX:TLB) announced that its smartphone investor relations application is now available for free download through Apple’s App Store. “The TearLab IR app was designed by Innovasium Digital to provide the investment community with direct and real-time mobile access to company news and information,” TearLab CEO Elias Vamvakas said in a statement. “We [...]

Analysts raise TearLab price targets

Tweet Craig-Hallum Capital Group and Feltl & Co. raised their price targets for TearLab (NASDAQ:TEAR; TSX:TLB) after the company reported fourth quarter financial results and a big jump in systems orders for its Osmolarity device to diagnose and monitor dry eye disease. Feltl analyst Ben Haynor, who rates TearLab as a “strong buy,” moved his [...]

TearLab revenue climbed more than three-fold in Q4

Tweet TearLab (NASDAQ:TEAR; TSX:TLB) posted fourth quarter revenue of $1.6-million, up more than three-fold from $499,000 for the same period in 2011, and an increase of 33% from $1.2-million in the third quarter last year. A total of 232 orders for TearLab systems were booked in the fourth quarter, the company said. Of those, 201 were [...]

Craig-Hallum ups TearLab price target to $7

Tweet Craig-Hallum Capital Group has raised its price target for “buy-rated” TearLab (NASDAQ:TEAR; TSX:TLB) to $7 from $5.50. “Post a very favorable experience at the American Academy of Ophthalmology (AAO), we see numerous signs of building physician interest and acceptance of the TearLab Osmolarity System,” writes analyst Stephen Crowley. “In fact, we believe the company’s [...]

Roth ups TearLab price target to $7

Tweet Roth Capital Partners has raised its price target on “buy-rated” TearLab (NASDAQ:TEAR; TSX:TLB) to $7 from $5, saying market awareness of TearLab is on the rise and TearLab system placements are expected to be strong in 2013. The stock closed at $5.48 on Monday. “Our valuation analysis now centers on our revenue projection for [...]

Canaccord ups TearLab price target to $8

Tweet Canaccord Genuity has raised its price target on “buy-rated” TearLab (NASDAQ:TEAR; TSX:TLB) to $8 from $6, saying the growth profile of the stock justifies a higher multiple than its peer group. The stock closed at $5.31 on Friday. “In our opinion, TearLab should start benefitting from physician referrals (>500 IB), expanding sales force (12 [...]

Next Page »